More on SLN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.3 Score)
- Holders

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Silence Therapeutics (NQ:SLN)
Delayed: 6.93 +0.17 (2.51%)
Prev. Close $6.76  
Open$6.82 
52 Wk High$0.27 
52 Wk Low$0.18 
Day High$7.00 
Day Low$6.52 
P/E N/A  
EPS$-0.44 
Volume382,922 

Friends, Peers and Foes (?): SLNCF (more...)

Jun 17, 2026 06:49 AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)
Jun 16, 2026 05:00 PM Form 8-K Silence Therapeutics For: Jun 16
Jun 11, 2026 07:35 AM Form 8-K Silence Therapeutics For: Jun 11
Jun 11, 2026 07:30 AM Silence Therapeutics presents divesiran follow-up data at EHA 2026
Jun 11, 2026 07:30 AM Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
May 28, 2026 06:04 AM Form EFFECT Silence Therapeutics
May 27, 2026 04:54 PM Form 424B5 Silence Therapeutics
May 27, 2026 08:00 AM Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
May 18, 2026 05:00 PM Form 8-K Silence Therapeutics For: May 18
May 18, 2026 04:11 PM Silence Therapeutics (SLN) files for $300M share offering
View All Articles

Entities mentioned with SLN

View All Entities